Cardarine, also known by its research designation GW501516, is a synthetic compound classified as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It was originally developed in the 1990s during a collaboration between pharmaceutical companies to investigate its effects on lipid metabolism and energy regulation in biological systems.